Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Vancomycin in CVVHDF with oXiris
NCT06543940Recruiting
- Sponsor
- Mahidol University
- Start
- Sep 2024
- Primary completion
- Aug 2025
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of vancomycin in bacterial infection, sponsored by Mahidol University. Primary endpoint: Area Under the Curve of Vancomycin. Started Sep 2024; status: recruiting.
02
Drugs
vancomycin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT06543940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06543940.